HER2 and response to paclitaxel in node-positive breast cancer
Mehta, R.
New England Journal of Medicine 358(2): 197-198; Author Reply 198
2008
ISSN/ISBN: 0028-4793 PMID: 18193531 Document Number: 617052
A 39-year-old patient was evaluated for pelvic pain and infection following a surgical abortion performed via aspiration curettage. A pelvic computed tomography (CT) revealed an invagination of fat in the uterine wall accompanied by an abscess in the rectouterine pouch. Laparoscopic exploration revealed an incarcerated cecal appendix within the myometrium with necrosis of the appendiceal base as the culprit. A posteriori, Ct multiplanar reconstruction allowed identification of the incarcerated appendix within the myometrium. To our knowledge, this Ct description is the only case described in the literature.
Document emailed within 1 workday
Related Documents
Saimura, M.; Mitsuyama, S.; Anan, K.; Tanaka, M.; Shimada, K.; Hirose, N.; Ogawa, S.; Tamaki, N.; Tomisaki, S.; Tamura, K. 2008: Adjuvant epirubicin and cyclophosphamide followed by weekly paclitaxel for Japanese women with node-positive breast cancer: a multi-institutional feasibility study Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(9): 1519-1523Spigel, D.R.; Hainsworth, J.D.; Burris, H.A.; Molthrop, D.C.; Peacock, N.; Kommor, M.; Vazquez, E.R.; Greco, F.A.; Yardley, D.A. 2011: A pilot study of adjuvant doxorubicin and cyclophosphamide followed by paclitaxel and sorafenib in women with node-positive or high-risk early-stage breast cancer Clinical Advances in Hematology and Oncology: H&o 9(4): 280-286
Ohsako, T.; Inoue, K.; Nagamoto, N.; Yoshida, Y.; Nakahara, O. 2006: Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(9): 1301-1303
Horiguchi, J.; Oyama, T.; Takata, D.; Rokutanda, N.; Nagaoka, R.; Odawara, H.; Tokiniwa, H.; Tozuka, K.; Kikuchi, M.; Sato, A.; Takeyoshi, I. 2011: Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience Anticancer Research 31(9): 3041-3046
Wang, Y.; Yao, L.; Liu, Y.-q.; Xu, Y.; Ou, Y.-t.; Li, J.-f.; Wang, T.-f.; Fan, Z.-q.; Fan, T.; Lin, B.-y.; Xie, Y.-t. 2010: Different influence of Her-2 expression on the prognosis in node-positive and node-negative breast cancer Zhonghua Zhong Liu Za Zhi 32(7): 511-514
Iwata, H.; Miura, S. 2002: Axillary lymph node dissection in clinically node-positive breast cancer Nihon Geka Gakkai Zasshi 103(11): 831-834
Rudan, I.; Skorić, T.; Rudan, N. 1994: Breast cancer prognosis. II. Prognostic factors in patients with node-positive (N1-3) breast cancer Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 48(4-5): 165-170
Seretis, C.; Seretis, F. 2016: Development of a novel scoring system to potentially avoid completion axillary lymph node clearance after breast cancer excision and positive sentinel lymph node biopsy Journal of BUON: Official Journal of the Balkan Union of Oncology 21(5): 1316-1319
Kubota, Y.; Nakano, M.; Nagai, S.; Matsuoka, K.; Arakawa, H.; Horie, K.; Deguchi, T.; Kato, H. 2015: Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report Hinyokika Kiyo. Acta Urologica Japonica 61(1): 33-37
Krsička, P.; Coufal, O.; Zapletal, O. 2013: Positive sentinel node in breast cancer - when and why also opt for axillary dissection? Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 92(12): 684-689
Salvadori, B.; Celio, L.; Oriana, R.; Bajetta, E. 2000: Adjuvant oophorectomy versus CMF in premenopausal node-positive breast cancer: long-term results of an experience at the Milan Cancer Institute Tumori 86(3): 258-259
Amanti, C.; Lombardi, A.; Maggi, S.; Moscaroli, A.; Lo Russo, M.; Maglio, R.; Provenza, G.; Romano, C.; Pezzatini, M.; Scopinaro, F.; Di Stefano, D. 2009: Is complete axillary dissection necessary for all patients with positive findings on sentinel lymph node biopsy? Validation of a breast cancer nomogram for predicting the likelihood of a non-sentinel lymph node Tumori 95(2): 153-155
Rai, Y.; Sagara, Y.; Sagara, Y.; Takahama, T.; Matsuyama, Y.; Ando, M.; Sagara, Y.; Ooi, Y.; Inoue, K.; Kurosumi, M. 2007: Preoperative therapy with trastuzumab and paclitaxel in a stage IV advanced breast cancer with complete pathologic response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(1): 65-68
Yoshida, T.; Horiguchi, J.; Koibuchi, Y.; Kanoh, T.; Iijima, K.; Yoshida, M.; Kikuchi, M.; Takata, D.; Oyama, T.; Iino, Y.; Morishita, Y. 2004: Metastatic breast cancer treated with trastuzumab and paclitaxel--a case report with clinically complete response Gan to Kagaku Ryoho. Cancer and ChemoTherapy 31(6): 907-910
Warm, M.; Kates, R.; Mallmann, P.; Dick, Mèlle.; Nawroth, F.; Harbeck, N.; Paepke, S.; Thomas, A. 2007: Impact of tumor biological factors on response to pre-operative epirubicin and paclitaxel chemotherapy in primary breast cancer Anticancer Research 27(2): 1031-1038
Li, Q.; Xu, B.-h. 2013: Clinical characteristic and management of HER-2 positive node negative small tumor breast cancer (pT1abN0) Zhonghua Yi Xue Za Zhi 93(2): 81-83
Sutepvarnon, A.; Warnnissorn, M.; Srimuninnimit, V. 2013: Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer Journal of the Medical Association of Thailand 96(Suppl 2): S60-S66
Domènech, A.; Benítez, A.; Bajén, M.T.; Ricart, Y.; Rodríguez-Gasén, A.; Palacín, J.A.; Català, I.; Gil, M.; Pernas, S.; García, A.; Martín-Comín, J. 2009: What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive? Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 53(4): 422-427
Bowles, D.W.; Rabinovitch, R.; Borges, V.; Urquhart, A.; Singh, M.; Finlayson, C.; Elias, A. 2007: A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score Oncology 21(10): 1212-1217
Kaya, S.; Aktas, B.; Tanrikulu Sismek, E.; Akif Ozturk, M.; Dede, F.; Kaya, H.; Ugurlu, U.; Ozgen, Z.; Koca, S.; Halil, S.; Hasanov, R.; Alan, O.; Akgul Babacan, N.; Ercelep, O.; Dane, F.; Gumus, M.; Yumuk, F. 2017: Changes in 18F-FDG-PET/CT tumor metabolism are not consistent with pathologic complete response in hormone-positive breast cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 22(5): 1191-1198